The Philippines’ pharmaceutical market is projected to grow from P525 billion in 2025 to P759 billion by 2030, with a compound annual growth rate of 7.6 percent, according to BMI Research.
The growth is expected to be driven by investments in local drug manufacturing and government initiatives, including a “green lane” to streamline regulatory processes for new facilities.
Despite these efforts, the country faces a $2.3-billion pharmaceutical trade deficit and remains heavily dependent on imported medicines.
Challenges to the sector’s expansion include limited financial resources, skilled human capital, and lengthy FDA approval processes that can delay product launches for years.
BMI noted that while policy measures support growth, structural constraints may continue to limit advanced pharmaceutical manufacturing and research in the Philippines.
Source: PhilNews24 | March 23, 2026
PHILIPPINE PHARMA MARKET GROWTH COULD TOP P759 BILLION BY 2030
Latest from Business
The Energy Regulatory Commission (ERC) warned that electricity bills in the Philippines could rise due to
Fuel prices in the Philippines are set to rise for the 10th consecutive week due to
Philippine retailers and manufacturers are preparing for the potential economic impact of a prolonged Middle East
The Philippines has begun talks with China, Russia, India, and Belarus to secure a steady supply
Globe Telecom Inc. has successfully tested Starlink Mobile to bring internet service to dead spots in